1
|
Négrier C, Abdul Karim F, Lepatan LM, Lienhart A, López‐Fernández MF, Mahlangu J, Pabinger I, Li Y, Wolko D, Voigt C, Jacobs I, Santagostino E. Efficacy and safety of long‐acting recombinant fusion protein linking factor
IX
with albumin in haemophilia B patients undergoing surgery. Haemophilia 2016; 22:e259-66. [DOI: 10.1111/hae.12972] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2016] [Indexed: 01/05/2023]
Affiliation(s)
- C. Négrier
- Centre Régional de Traitement de l'Hémophilie (CRTH)/Unite d'Hemostase Clinique Hôpital Cardiologique Louis Pradel University Lyon I Lyon France
| | | | | | - A. Lienhart
- Centre Régional de Traitement de l'Hémophilie (CRTH)/Unite d'Hemostase Clinique Hôpital Cardiologique Louis Pradel University Lyon I Lyon France
| | | | - J. Mahlangu
- Haemophilia Clinic Comprehensive Care Centre Charlotte Maxeke Johannesburg Academic Hospital and Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa
- NHLS South Africa Johannesburg South Africa
| | - I. Pabinger
- Clinical Division of Haematology and Haemostaseology Medical Clinic I Medical University Vienna Vienna Austria
| | - Y. Li
- Clinical Research and Development CSL Behring King of Prussia PA USA
| | - D. Wolko
- Clinical Research and Development CSL Behring King of Prussia PA USA
| | - C. Voigt
- Clinical Research and Development CSL Behring King of Prussia PA USA
| | - I. Jacobs
- Clinical Research and Development CSL Behring King of Prussia PA USA
| | - E. Santagostino
- A. Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS Ca' Granda Foundation Maggiore Hospital Policlinico Milan Italy
| |
Collapse
|